Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged ≥ 13 years.
Hiroo YokozekiHiroyuki MurotaTakayo MatsumuraHiroshi Komazakinull nullPublished in: The British journal of dermatology (2024)
Improvements in PN were greater following nemolizumab treatment, despite continuation of topical corticosteroids in both groups.